# Commission Implementing Decision (EU) 2020/569 of 16 April 2020 establishing a common format and information content for the submission of the information to be reported by Member States pursuant to Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes and repealing Commission Implementing Decision 2012/707/EU (notified under document C(2020) 2179) (Text with EEA relevance), Division 21.1

Extent: E+W+S+N.I.

Routine production by product type covers the production of antibodies and blood products using established methods. This excludes immunisation of animals for subsequent hybridoma production when carried out for the purposes of basic or applied research within a given project. That immunisation shall be captured under basic or applied research under the appropriate category.

---
Source: https://www.legislation.gov.uk/eudn/2020/569/annex/III/part/B/division/B/division/21/division/21.1 (the official version)
Page: https://openlegislation.uk/eu-decision-2020-569/annex-III/part-B/division-B/division-21/division-21.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.